Cefixime + Moxifloxacin HCl Tablets Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness exports Cefixime + Moxifloxacin HCl Tablets for difficult-to-treat bacterial infections requiring extended-spectrum oral antibacterial therapy. The formulation is widely used in lower respiratory tract infections, typhoid fever, gastrointestinal infections, and bacterial conditions where broader pathogen coverage is necessary.

Cefixime works against susceptible bacterial organisms through inhibition of bacterial cell wall synthesis, while Moxifloxacin HCl interferes with bacterial DNA replication mechanisms. As a recognized Advanced Oral Antibiotic Exporter, Genliva Wellness develops combination antibacterial formulations designed for enhanced bacterial eradication and infection management.

Operating as a Cefixime Moxifloxacin Tablets Manufacturer in India, Genliva Wellness LLP supplies advanced antibiotic formulations to pharmaceutical distributors and international healthcare supply markets.

Cefixime + Moxifloxacin HCl Tablets are formulated for advanced broad-spectrum antibacterial treatment.

Cephalosporin and fluoroquinolone combination
Effective against complicated bacterial infections
Helps manage respiratory and gastrointestinal infections
Stable oral tablet dosage form

This formulation is commonly used for complicated bacterial infection treatment.

Treatment of lower respiratory tract infections
Management of typhoid and gastrointestinal infections
Used in resistant bacterial infection therapies
Helps control broad-spectrum bacterial growth
Improves recovery from complicated infections
Used in advanced oral antibiotic treatment protocols

Cefixime + Moxifloxacin HCl Tablets deliver enhanced broad-spectrum antibacterial therapy.

Effective against difficult bacterial infections
Useful in respiratory and typhoid infection treatment
Provides dual antibacterial mechanisms of action
Helps improve bacterial eradication effectiveness
Delivers dependable oral antibacterial coverage
Suitable for advanced infection management care